Publications by authors named "Takeshi Kitazaki"

Claim this Profile
A
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.
Fumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto, Ryosuke Ogata, Yasuhiro Umeyama, Takeshi Kitazaki

J Thorac Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a novel rapid TRC assay for the detection of influenza using nasopharyngeal swabs and gargle samples.
Norihito Kaku, Kohji Hashiguchi, Norihiko Akamatsu, Fumiko Wakigawa, Junichi Matsuda, Takeshi Kitazaki

Eur J Clin Microbiol Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).
Kaname Nosaki, Takeharu Yamanaka, Akinobu Hamada, Yoshimasa Shiraishi, Taishi Harada, Takeshi Kitazaki

Oncologist· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study.
Takaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, Hiroshi Gyotoku, Hirokazu Taniguchi, Takeshi Kitazaki

Thorac Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in -Mutated Non-Small Cell Lung Cancer.
Naoko Okura, Naoya Nishioka, Tadaaki Yamada, Hirokazu Taniguchi, Keiko Tanimura, Takeshi Kitazaki

Clin Cancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.
Shinnosuke Takemoto, Minoru Fukuda, Hiroyuki Yamaguchi, Takaya Ikeda, Kazumasa Akagi, Takeshi Kitazaki

Thorac Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancer.
Hirokazu Taniguchi, Hiroyuki Yamaguchi, Yosuke Dotsu, Midori Shimada, Hiroshi Gyotoku, Takeshi Kitazaki

Thorac Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201).
Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara, Masao Ichiki, Hiroshi Mukae

Lung Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer.
Mio Mori, Hideyuki Hayashi, Minoru Fukuda, Sumihisa Honda, Takeshi Kitazaki

Thorac Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
Noriho Sakamoto, Hiroshi Ishimoto, Shota Nakashima, Hirokazu Yura, Takuto Miyamura, Takeshi Kitazaki

Intern Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.
Shinnosuke Takemoto, Yoichi Nakamura, Hiroshi Gyoutoku, Hiroaki Senju, Daiki Ogawara, Takeshi Kitazaki

Thorac Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang, Keiko Tanimura, Yuta Adachi, Takeshi Kitazaki

Nat Commun· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of FilmArray respiratory panel multiplex polymerase chain reaction assay for detection of pathogens in adult outpatients with acute respiratory tract infection.
Norihito Kaku, Kohji Hashiguchi, Yuki Iwanaga, Norihiko Akamatsu, Junichi Matsuda, Takeshi Kitazaki

J Infect Chemother· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Artery Sarcoma Overexpressing Platelet-derived Growth Factor Receptor α.
Shinnosuke Takemoto, Hiroshi Soda, Keisuke Iwasaki, Takeshi Kitazaki, Makoto Sumiyoshi

Intern Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction.
Midori Shimada, Minoru Fukuda, Masaaki Fukuda, Takeshi Kitazaki, Kohji Hashiguchi

Onco Targets Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Immunohistochemical Protein Levels in Anaplastic Lymphoma Kinase-positive Lung Adenocarcinoma Possibly due to Chemo-radiotherapy.
Hirokazu Taniguchi, Takaya Ikeda, Hiroshi Soda, Yuichi Fukuda, Takeshi Kitazaki

Intern Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Mediastinal Large B-cell Lymphoma Exhibiting Endobronchial Involvement.
Midori Shimada, Minoru Fukuda, Kensuke Horio, Takayuki Suyama, Takeshi Kitazaki

Intern Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).
Minoru Fukuda, Midori Shimada, Takeshi Kitazaki, Seiji Nagashima, Kohji Hashiguchi

Thorac Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.
Takashi Kasai, Yoichi Nakamura, Minoru Fukuda, Takeshi Kitazaki, Seiji Nagashima

Chemotherapy· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).
Minoru Fukuda, Takayuki Suetsugu, Midori Shimada, Takeshi Kitazaki, Kohji Hashiguchi

Thorac Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A severe case of Lemierre Syndrome with Streptococcus constellatus Infection.
Midori Shimada, Yoshitomo Morinaga, Takeshi Kitazaki, Minoru Fukuda, Kohji Hashiguchi

Jpn J Infect Dis· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy.
Takeshi Kitazaki, Yuichi Fukuda, Susumu Fukahori, Kazuhiko Oyanagi, Hiroshi Soda

Support Care Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
Takaya Ikeda, Minoru Fukuda, Yoichi Nakamura, Akitoshi Kinoshita, Hiroaki Senju, Takeshi Kitazaki

Cancer Chemother Pharmacol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous remission of a non-small cell lung cancer possibly caused by anti-NY-ESO-1 immunity.
Yoichi Nakamura, Yuji Noguchi, Eiichi Satoh, Akiko Uenaka, Shuichiro Sato, Takeshi Kitazaki

Lung Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin.
Hiroshi Ishimoto, Hiroshi Mukae, Noriho Sakamoto, Misato Amenomori, Takeshi Kitazaki

J Antimicrob Chemother· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis